
|Articles|November 29, 2012
New drug promising for psoriatic arthritis
An oral phosphodiesterase 4 inhibitor may offer significant improvement in signs and symptoms of psoriatic arthritis, according to preliminary trial data.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Social Media Mythbusters: Hydrocolloid Pimple Patches
2
Common Mistakes in Managing Hair Loss and Pigmentary Disorders
3
Clinicians Weigh Topical Sequencing and Escalation in Complex Atopic Dermatitis Cases
4
CSU With Biochemical C1 Inhibitor Deficiency: Case Report Raises Diagnostic Questions
5











